Although miR-31 has been shown to act as either an oncomiR or tumor suppressor in various tumor types [13], in this study we clearly establish miR-31 as a tumor suppressor, demonstrate that it targets multiple oncogenes such as SRC, MET, NIK and RAB27a and regulates the expression of EZH2 in melanoma. This evidence concerns the gene EZH2 and neoplasm.